The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Determining the Minimal Clinically Important Difference and Responsiveness of the Dermatology Life Quality Index (DLQI): Further Data
Open accessAbstract
Aims: To determine the minimal clinically important difference (MCID) of the Dermatology Life Quality Index (DLQI) and its responsiveness to change in inflammatory skin diseases. Methods: A longitudinal study: at stage 1, patients completed the DLQI and a disease severity global question; at stage 2, a global rating of change in quality of life (QoL; Global Rating of Change Questionnaire, GRCQ) was added and used as an anchor to measure the MCID of the DLQI. Results: 192 patients completed stage 1 and 107 completed stage 2. The mean DLQI score at stage 1 was 9.8 and 7.4 at stage 2 with a mean change of 2.4 (p < 0.0001). 31 patients experienced a ‘small change' in their QoL (±3 and ±2) on the GRCQ. The mean corresponding change in DLQI scores was 3.3, which is regarded as the approximate MCID. Conclusions: Previous estimates of the MCID of the DLQI have varied from 3 to 5. Although this study demonstrated a MCID of 3.3, we recommend that the MCID in inflammatory skin diseases should be 4.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use
FINLAY, A. Y., & KHAN, G. K. (1994) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1994.tb01167.x · Cited by 5,586
Self-citationJaeschke, R., Singer, J., & Guyatt, G. H. (1989) · Controlled Clinical Trials · doi:10.1016/0197-2456(89)90005-6 · Cited by 4,982
U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, & U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health (2006) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-4-79 · Cited by 2,856
Measuring change over time: Assessing the usefulness of evaluative instruments
Guyatt, G., Walter, S., & Norman, G. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90069-5 · Cited by 1,880
Determining a minimal important change in a disease-specific quality of life questionnaire
JUNIPER, E. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90036-1 · Cited by 1,824
Defining clinically meaningful change in health-related quality of life
Crosby, R. D., Kolotkin, R. L., & Williams, G. R. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(03)00044-1 · Cited by 1,332
Hongbo, Y., Thomas, C. L., Harrison, M. A., Sam Salek, M., & Finlay, A. Y. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23621.x · Cited by 854
Self-citationBasra, M. K. A., Fenech, R., Gatt, R. M., Salek, M. S., & Finlay, A. Y. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08832.x · Cited by 789
Self-citationNorman, G. R., Stratford, P., & Regehr, G. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00097-8 · Cited by 524
Beaton, D. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00407-3 · Cited by 487
10 Years Experience of the Dermatology Life Quality Index (DLQI)
Lewis, V., & Finlay, A. Y. (2004) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1111/j.1087-0024.2004.09113.x · Cited by 479
Self-citationResponsiveness and minimal important differences for patient reported outcomes
Revicki, D. A., Cella, D., Hays, R. D., Sloan, J. A., Lenderking, W. R., & Aaronson, N. K. (2006) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-4-70 · Cited by 476
British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009
Smith, C. H., Anstey, A. V., Barker, J. N. W. N., Burden, A. D., Chalmers, R. J. G., Chandler, D. A., Finlay, A. Y., Griffiths, C. E. M., Jackson, K., McHugh, N. J., et al. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09505.x · Cited by 464
Self-citationSensitivity to Change of the Roland-Morris Back Pain Questionnaire: Part 1
Stratford, P. W., Binkley, J. M., Riddle, D. L., & Guyatt, G. H. (1998) · Physical Therapy · doi:10.1093/ptj/78.11.1186 · Cited by 425
Critical Review of Generic and Dermatology-Specific Health-Related Quality of Life Instruments
Both, H., Essink-Bot, M.-L., Busschbach, J., & Nijsten, T. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701142 · Cited by 327
Sensitivity to Change of the Roland-Morris Back Pain Questionnaire: Part 2
Riddle, D. L., Stratford, P. W., & Binkley, J. M. (1998) · Physical Therapy · doi:10.1093/ptj/78.11.1197 · Cited by 277
Shikiar, R., Willian, M. K., Okun, M. M., Thompson, C. S., & Revicki, D. A. (2006) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-4-71 · Cited by 210
Sampogna, F., Sera, F., & Abeni, D. (2004) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2003.09101.x · Cited by 191
Twiss, J., Meads, D. M., Preston, E., Crawford, S. R., & McKenna, S. P. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.238 · Cited by 134
Nijsten, T. E. C., Meads, D. M., de Korte, J., Sampogna, F., Gelfand, J. M., Ongenae, K., Evers, A. W. M., & Augustin, M. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700875 · Cited by 122
Simplifying Outcome Measurement
Hägg, O., Fritzell, P., Odén, A., & Nordwall, A. (2002) · Spine · doi:10.1097/00007632-200206010-00014 · Cited by 111
Mazzotti, E., Barbaranelli, C., Picardi, A., ABENI, D. D., & Pasquini, P. (2005) · Acta Dermato Venereologica · doi:10.1080/00015550510032832 · Cited by 110
Shikiar, R., Harding, G., Leahy, M., & Lennox, R. D. (2005) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-3-36 · Cited by 107
The minimal important difference: Who's to say what is important?
Wright, J. G. (1996) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00207-7 · Cited by 103
Dermatology Life Quality Index: influence of an illustrated version
Loo, W. J., Diba, V. C., Chawla, M. K., et al. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05158.x · Cited by 48
Poor Reporting of Quality of Life Outcomes in Dermatology Randomized Controlled Clinical Trials
Cleach, L. L., Chassany, O., Levy, A., Wolkenstein, P., & Chosidow, O. (2007) · Dermatology · doi:10.1159/000109358 · Cited by 47
Dimensionality of the Dermatology Life Quality Index (DLQI): A Commentary
Nijsten, T. E. C., Meads, D., & McKenna, S. P. (2006) · Acta Dermato Venereologica · doi:10.2340/00015555-0075 · Cited by 43
Cited by
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Simpson, E. L., Bieber, T., Guttman-Yassky, E., Beck, L. A., Blauvelt, A., Cork, M. J., Silverberg, J. I., Deleuran, M., Kataoka, Y., Lacour, J.-P., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1610020 · Cited by 2,110
Blauvelt, A., de Bruin-Weller, M., Gooderham, M., Cather, J. C., Weisman, J., Pariser, D., Simpson, E. L., Papp, K. A., Hong, H. C.-H., Rubel, D., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31191-1 · Cited by 1,261
de Bruin-Weller, M., Thaçi, D., Smith, C. H., Reich, K., Cork, M. J., Radin, A., Zhang, Q., Akinlade, B., Gadkari, A., Eckert, L., et al. (2018) · British Journal of Dermatology · doi:10.1111/bjd.16156 · Cited by 479
Mouelhi, Y., Jouve, E., Castelli, C., & Gentile, S. (2020) · Health and Quality of Life Outcomes · doi:10.1186/s12955-020-01344-w · Cited by 450
Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus
Kabashima, K., Matsumura, T., Komazaki, H., & Kawashima, M. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1917006 · Cited by 361
Metadata
- Authors
- Basra, M. K. A., Salek, M. S., Camilleri, L., Sturkey, R., & Finlay, A. Y.
- Venue
- Dermatology
- Publisher
- S. Karger AG
- Published
- 2015
- Volume
- 230
- Issue
- 1
- Pages
- 27-33
- ISSN
- 1018-8665 (ISSN-L)
- 1421-9832
- OpenAlex
- W2058562555
- Cited by
- 441
- References
- 27
- FWCI
- 28.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.